Shell, Richard et al "AVXS-101 Phase 1 Gene Replacement Therapy Clinical Trial in SMA Type 1: Continued Independence from Nutritional and Ventilatory Support in Patients Dosed Early in Disease Progression (S29.003)." Neurology 90.15 Supplement (2018): S29.003. Web. 25 Oct. 2021.